WANBURY
Back to Cashflow Statement
|
WANBURY Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹3.98 Cr | ₹20 Cr | ₹41 Cr | ₹17 Cr | ₹44 Cr |
What is the latest Cash Flow from Operating Activities ratio of WANBURY ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹3.98 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹41 Cr |
Mar2021 | ₹17 Cr |
Mar2020 | ₹44 Cr |
How is Cash Flow from Operating Activities of WANBURY Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹3.98 Cr | -79.91 | |
Mar2023 | ₹20 Cr | -51.15 | |
Mar2022 | ₹41 Cr | 142.91 | |
Mar2021 | ₹17 Cr | -62.20 | |
Mar2020 | ₹44 Cr | - |
Compare Cash Flow from Operating Activities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹887.8 Cr | -2.5% | -4.7% | 42.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -2.5% |
-4.7% |
42.1% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses